• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

U.S. plant-based vaccine facility opens targeted to produce 10 million doses of pandemic influenza vaccine per month

Emily

Editor, Senior Moderator
The facility has a fully-automated greenhouse.

http://www.marketwatch.com/story/medicago-holds-official-ribbon-cutting-ceremony-for-its-us-plant-based-vaccine-facility-2011-11-10-7000?reflink=MW_news_stmp
press release

Nov. 10, 2011, 7:00 a.m. EST
Medicago holds official ribbon cutting ceremony for its U.S. plant-based vaccine facility
RALEIGH, North Carolina and QUEBEC CITY, Quebec, Nov. 10, 2011 /PRNewswire via COMTEX/
[snip]
Medicago intends to demonstrate its capacity to produce 10 million doses/month of influenza vaccines with the potential for further expansion in the future. This DARPA project is part of the Blue Angel influenza vaccine rapid response demonstration project which seeks to identify new ways to produce large amounts of high quality vaccine grade protein in less than 3 months in response to emerging and novel biologic threats...
 
Back
Top Bottom